BPC-157

Review BPC-157 tendon experiments, human knee-pain reports, the two-person safety pilot and FDA findings, with clear limits on clinical claims.

GHRP-6

Examine GHRP-6 human hormone and sleep studies, pharmacokinetics, metabolic findings, animal gut research and safety limits.

Cortagen

Evaluate Cortagen tissue-culture and mouse-heart research while distinguishing Cortexin identity, molecular signals and unverified clinical claims.

GHK-Cu

Examine GHK-Cu wound models, the human laser-resurfacing trial, skin penetration research and injectable safety concerns using original sources.

GHRP-2

Review GHRP-2 human appetite and growth studies, diagnostic hormone responses, the negative pediatric trial and FDA safety concerns.

HMG

Review HMG and menotropins evidence, the MERIT fertility trial, combination treatment research and the limits of comparing pregnancy rates.

LL-37

Read LL-37 wound-healing research in context: venous-ulcer and diabetic-foot trials, mixed outcomes, antimicrobial claims and FDA safety concerns.

Prostamax

Examine Prostamax rat prostate-culture and human-cell chromatin research without equating structural signals with proven urinary or prostate benefits.

SS-31

Review SS-31 and elamipretide trials, negative myopathy results, the specific Forzinity approval for Barth syndrome and safety considerations.

Tesamorelin

Understand tesamorelin evidence for HIV-associated abdominal fat, liver research, hormone findings, safety limits and formulation differences.